Trial Profile
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin (P2)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms AZ11040
- 02 Dec 2019 Status changed from active, no longer recruiting to completed.
- 06 Feb 2019 Planned End Date changed from 31 Jan 2020 to 16 Nov 2019.
- 06 Feb 2019 Status changed from recruiting to active, no longer recruiting.